
Pfizer Initiates Second Legal Challenge Against Metsera and Novo Nordisk
Pfizer Inc has lodged a follow-up lawsuit in Delaware’s federal court targeting drug developer Metsera, its primary shareholder, and Danish

Pfizer Inc has lodged a follow-up lawsuit in Delaware’s federal court targeting drug developer Metsera, its primary shareholder, and Danish

Pharmaceutical company Pfizer is close to finalizing a $7.3bn takeover of Metsera, a biotech company developing next-generation obesity treatments, in

American drugmaker Pfizer has said it plans to reduce the amount of time it takes to produce a batch of

The makers of Pfizer and BioNTech coronavirus vaccine said on Thursday that their vaccine is only slightly less effective against

WHO Director-General Tedros Adhanom Ghebreyesus has expressed concern about wealthy nations buying up the supply of vaccines and leaving none

The United Kingdom (UK) on Wednesday approved the Pfizer-BioNTech vaccine for the novel coronavirus disease, to be rolled out and

In terms of distribution, which is the foremost challenge in getting a vaccine across the world, the AstraZeneca vaccine will

According to reports, wealthier hospitals in the United States have started buying up expensive specialized freezers for Pfizer’s vaccine, raising

Meanwhile, African leaders have so far only welcomed news of the effective shots without obvious efforts to secure doses of

The Nigerian Markets Last Week for the week ended November 13, 2020. Stock Market The Nigerian Stock Exchange All-Share Index

The European Union has negotiated to buy up to 300 million doses of the breakthrough coronavirus vaccine developed by BioNTech

American multinational Pfizer today said early results from a trial of its coronavirus vaccine, developed in collaboration with German biotech











Get notified about new articles